Goserelin (Zoladex) in premenopausal advanced breast cancer: duration of response and survival.

In premenopausal women with advanced breast cancer the luteinising hormone-releasing hormone agonist goserelin (Zoladex, ICI plc) will produce serum levels of oestradiol equivalent to those following surgical oophorectomy or the menopause. This paper reports our further experience of using this drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Dixon, A. R., Robertson, J. F., Jackson, L., Nicholson, R. I., Walker, K. J., Blamey, R. W.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1990
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971509/
https://www.ncbi.nlm.nih.gov/pubmed/2147110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971509/
https://www.ncbi.nlm.nih.gov/pubmed/2147110

Ejemplares similares